Wall Street JournalEN
A
APS
Aptose Bio
0.26
-0.01-3.70%Closed15:54 12/11 EST
OPEN/PREV CLOSE0.275/0.270
TODAY RANGE0.255-0.275
VOL31.04K
MARKET CAP5.08M
52 WEEK RANGE0.190-3.750
AVG VOL (3M)19.31K
% TURNOVER0.16%
TURNOVER8.18K
P/E (TTM)-0.0306
% RANGE7.41%
EPS(TTM)-8.5022
P/E(FORWARD)-0.0425
P/B22.03
BVPS0.012
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.25M
SHARES OUTSTANDING19.52M
NEXT EARNINGS03/24-03/28
FREE FLOAT16.33M
LOT SIZE500
EX-DIV DATE06/06/2023
News
Press Releases
Financial Reports
Profile
Dow Jones·12/03 17:31
Aptose Biosciences Price Target Maintained With a $2.00/Share by HC Wainwright & Co.
Dow Jones·11/20 18:11
Aptose Biosciences Is Maintained at Buy by HC Wainwright & Co.
Dow Jones·11/20 18:11
Aptose Biosciences Price Target Cut to $2.00/Share From $7.00 by HC Wainwright & Co.
Dow Jones·11/08 21:01
*Aptose Biosciences 3Q Loss/Shr 37c >APTO
Dow Jones·08/08 21:12
*Aptose Biosciences Sees Funding Sufficient Through August >APTO
Dow Jones·06/14 15:13
Aptose Biosciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Dow Jones·05/16 15:57
Aptose Biosciences Price Target Cut to $6.00/Share From $15.00 by Canaccord Genuity
Dow Jones·05/16 15:57
Aptose Biosciences Is Maintained at Buy by Canaccord Genuity
Dow Jones·05/14 20:05
*Aptose Biosciences 1Q Loss/Shr 73c >APTO
Dow Jones·05/14 20:01
Press Release: Aptose Reports Results for the -2-
Dow Jones·04/03 16:09
Aptose Biosciences Is Maintained at Overweight by Piper Sandler
Dow Jones·04/03 16:09
Aptose Biosciences Price Target Maintained With a $5.00/Share by Piper Sandler
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others